GADARA, Darshak Chandulal, Kateřina COUFALÍKOVÁ, Juraj BOSÁK, David ŠMAJS and Zdeněk SPÁČIL. Systematic Feature Filtering in Exploratory Metabolomics: Application toward Biomarker Discovery. Analytical chemistry. WASHINGTON: AMER CHEMICAL SOC, 2021, vol. 93, No 26, p. 9103-9110. ISSN 0003-2700. Available from: https://dx.doi.org/10.1021/acs.analchem.1c00816.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Systematic Feature Filtering in Exploratory Metabolomics: Application toward Biomarker Discovery
Authors GADARA, Darshak Chandulal (356 India, belonging to the institution), Kateřina COUFALÍKOVÁ (203 Czech Republic, belonging to the institution), Juraj BOSÁK (703 Slovakia, belonging to the institution), David ŠMAJS (203 Czech Republic, belonging to the institution) and Zdeněk SPÁČIL (203 Czech Republic, guarantor, belonging to the institution).
Edition Analytical chemistry, WASHINGTON, AMER CHEMICAL SOC, 2021, 0003-2700.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10406 Analytical chemistry
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.008
RIV identification code RIV/00216224:14310/21:00119354
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1021/acs.analchem.1c00816
UT WoS 000672115800013
Keywords in English SPECTROMETRY-BASED METABOLOMICS; LC-MS METABOLOMICS; ANNOTATION; TOOLS; CHALLENGES; SOFTWARE; XCMS
Tags 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 28/2/2022 11:05.
Abstract
Exploratory mass spectrometry-based metabolomics generates a plethora of features in a single analysis. However, >85% of detected features are typically false positives due to inefficient elimination of chimeric signals and chemical noise not relevant for biological and clinical data interpretation. The data processing is considered a bottleneck to unravel the translational potential in metabolomics. Here, we describe a systematic workflow to refine exploratory metabolomics data and reduce reported false positives. We applied the feature filtering workflow in a case/control study exploring common variable immunodeficiency (CVID). In the first stage, features were detected from raw liquid chromatography-mass spectrometry data by XCMS Online processing, blank subtraction, and reproducibility assessment. Detected features were annotated in metabolomics databases to produce a list of tentative identifications. We scrutinized tentative identifications' physicochemical properties, comparing predicted and experimental reversed-phase liquid chromatography (LC) retention time. A prediction model used a linear regression of 42 retention indices with the cLogP ranging from -6 to 11. The LC retention time probes the physicochemical properties and effectively reduces the number of tentatively identified metabolites, which are further submitted to statistical analysis. We applied the retention time-based analytical feature filtering workflow to datasets from the Metabolomics Workbench (www. metaboloinicsworkbench.org ), demonstrating the broad applicability. A subset of tentatively identified metabolites significantly different in CVID patients was validated by MS/MS acquisition to confirm potential CVID biomarkers' structures and virtually eliminate false positives. Our exploratory metabolomics data processing workflow effectively removes false positives caused by the chemical background and chimeric signals inherent to the analytical technique. It reduced the number of tentatively identified metabolites by 88%, from initially detected 6940 features in XCMS to 839 tentative identifications and streamlined consequent statistical analysis and data interpretation.
Links
EF15_003/0000469, research and development projectName: Cetocoen Plus
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
GJ17-24592Y, research and development projectName: Mapování interakcí mezi základními metabolickými pochody a střevní mikroflórou
Investor: Czech Science Foundation
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
MUNI/G/1131/2017, interní kód MUName: Transformative stem cell-based model of Alzheimer’s disease and advanced analytics to study the role of membrane lipids in the pathogenesis
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects
NV19-08-00472, research and development projectName: Klinicky relevantní biochemické, imunologické a buněčné biomarkery Alzheimerovy nemoci a stárnutí (Acronym: BioMAD)
Investor: Ministry of Health of the CR
PrintDisplayed: 20/7/2024 04:17